| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Sangamo Therapeutics, Inc (SGMO) has 14 insiders with recent SEC Form 4 filings, including 3 buys and 7 sells. SGMO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.91M | $193.1K | - | |
| Other | 696.7K | $70.5K | - | |
| VP | 678.7K | $68.7K | - | |
| VP | 651.4K | $65.9K | - | |
| Other | 237.2K | $24.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 14, 2018 | Parker H Stewart | Director | Buy | 2,000 | $9.00 | $18,001.60 | +36.4% | |
| Nov 6, 2018 | Conner Edward R. | Sr. VP &Chief Medical Officer | Sale+OE | 5,000 | $13.73 | $68,650.00 | -29.2% | |
| Oct 15, 2018 | Yi Kathy | SVP &Chief Financial Officer | Sale+OE | 5,000 | $13.97 | $69,850.00 | -40.8% | |
| Oct 8, 2018 | Conner Edward R. | Sr. VP &Chief Medical Officer | Sale+OE | 5,000 | $14.55 | $72,773.50 | -33.1% | |
| Sep 17, 2018 | Yi Kathy | SVP &Chief Financial Officer | Sale+OE | 5,000 | $14.66 | $73,284.50 | -40.8% | |
| Sep 7, 2018 | Jeffs Roger67 | Director | Buy | 7,408 | $13.56 | $100,486.56 | +296.3% | |
| Sep 7, 2018 | Parker H Stewart | Director | Buy | 2,000 | $13.52 | $27,040.00 | +57.1% | |
| Sep 6, 2018 | Conner Edward R. | Sr. VP &Chief Medical Officer | Sale+OE | 5,000 | $14.17 | $70,845.00 | -33.1% | |
| Aug 16, 2018 | Yi Kathy | SVP &Chief Financial Officer | Sale+OE | 5,000 | $15.39 | $76,951.50 | -40.8% | |
| Aug 6, 2018 | Conner Edward R. | Sr. VP &Chief Medical Officer | Sale+OE | 5,000 | $13.45 | $67,250.00 | -33.1% |